A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

NCT00717314 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Mycophenolate mofetil
DRUG: CNI (50%)
DRUG: CNI (≥75%)

Sponsor

Hoffmann-La Roche